SCHEMBL26656463

SCHEMBL26656463

COc1nccc2c(O)c(C#N)cnc12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAP2K1 Q02750 1/20 0.36
▸ GAA P10253 1/20 0.35
▸ EGFR P00533 5/20 0.35
▸ ERBB2 P04626 5/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ KMT2A Q03164 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ SLC6A3 Q01959 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ SRC P12931 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CRHBP P24387 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ CRHR2 Q13324 1/20 0.33
▸ HPGDS O60760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30666122 1.00 MAP2K1 (0.36) MAP2K1GAAEGFRERBB2ALDH1A1
SCHEMBL26864347 0.85 GAA (0.35) GAAEGFRERBB2ALDH1A1SMN1; SMN2
SCHEMBL26656444 0.84 L3MBTL1 (0.38) GAAEGFRERBB2KMT2AMAPK1
SCHEMBL6384752 0.74 SLC6A3 (0.46) MAP2K1GAAEGFRERBB2ALDH1A1
SCHEMBL31702261 0.73 MAP2K1 (0.40) MAP2K1EGFRERBB2ALDH1A1SMN1; SMN2
SCHEMBL31700880 0.72 MTNR1A (0.37) ALDH1A1KMT2AMEN1KDM4EMAPK1
SCHEMBL23803683 0.71 EGFR (0.36) MAP2K1EGFRERBB2SLC6A3SRC
SCHEMBL6380575 0.71 SRC (0.49) MAP2K1EGFRERBB2SRC
SCHEMBL31700843 0.70 MAPT (0.38) ALDH1A1KMT2AMEN1KDM4EMAPK1
SCHEMBL26863122 0.70 MAP2K1 (0.43) MAP2K1EGFRERBB2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320204-A1 7-AZA BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC (US) 2025-10-16 — — US disclosed
WO-2023225001-A1 NAPHTHYRIDINE BASED ENPP1 MODULATORS AND USES THEREOF Vir Biotechnology, Inc. (US) 2023-11-23 — — WO disclosed
WO-2023225001-A1 NAPHTHYRIDINE BASED ENPP1 MODULATORS AND USES THEREOF Vir Biotechnology, Inc. (US) 2023-11-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320204-A1 7-AZA BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS ENPP1, ENPP3, PDE7A MAP2K1 2581/4885GAA 188/4885EGFR 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback